Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Can microvascular damage predict disease severity in patients with systemic sclerosis?
Ana Martins; Sofia Pimenta; Daniela Oliveira; Raquel Miriam Ferreira; Miguel Bernardes; Lúcia Costa; Georgina Terroso;
Reumatol Clin. 2024;20:366-71
Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters
Abeer M. Ghandour; Rania M. Gamal; Gehan Seif Eldein; Aya M. Gamal; Eman El-Hakeim; Marwa A.A. Galal; Fatma H. El-Nouby; Yasmine S. Makarem; Ahmed Abdellatif Awad; Ahmed A. Hafez; Hanan Sayed M. Abozaid;
Reumatol Clin. 2022;18:597-602
Anti-RNA polymerase III antibodies in systemic sclerosis: Multicentric study from Argentina
María de los Ángeles Gargiulo; Nicolás Perez; Marina Khoury; Manuel Buhl; Lorena Suárez; Judith Sarano; Fabiana Montoya; Ignacio Bazzalo; Sandra Navarro; Gisela Pendón; María Josefina Molina; Marta Mamani; Mariano Rivero; Graciela Gómez;
Reumatol Clin. 2022;18:368-73